Clinical trial NCT00933205: An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Official title: An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Study type: EXPANDED_ACCESS
Overall status: APPROVED_FOR_MARKETING
Conditions: HIV Infections
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2009-07-07
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no

Brief summary: The purpose of this Open Label Safety Study is to provide access to and evaluate the safety and tolerability of TPV/r in treatment-experienced patients with advanced HIV-1 infection who have failed at least two PI-containing regimens, and have limited treatment options.


Eligibility criteria: Inclusion Criteria:

1. Triple anti-retroviral class experienced patients with at least 2 previous PI-based regimens who had failed or are intolerant to currently approved HIV-1 treatments.
2. Age equal or more than 18 years
3. Patient is willing to use an effective barrier method of contraception for the duration of study participation and up to three months thereafter
4. Patient voluntarily provides written informed consent to participate, in compliance with local law.

Exclusion Criteria:

1. Hypersensitivity to active ingredients or any of the excipients in tipranavir or ritonavir
2. Required use of restricted medications.
3. Female patients of childbearing potential who have a positive pregnancy test at baseline or are breast feeding.
4. Any medical condition which in the opinion of the investigator would interfere with the patients' ability to participate in or adhere to the requirements of this protocol.
5. Use of other investigational drugs, within 30 days prior to TPV boosted with ritonavir initiation and for the duration of study participation
6. Hepatic impairment evidenced by the following baseline laboratory findings:

   * AST or ALT more than 5X ULN or total bilirubin more than 3.5X ULN
   * AST or ALT more 2.5X ULN and total bilirubin more 2X ULN

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: Antwerpen
country: Belgium
facility: 1182.16.3202 Boehringer Ingelheim Investigational Site
city: Brussel
country: Belgium
facility: 1182.16.3203 Boehringer Ingelheim Investigational Site
city: Bruxelles
country: Belgium
facility: 1182.16.3205 Boehringer Ingelheim Investigational Site
city: Bruxelles
country: Belgium
facility: 1182.16.3206 Boehringer Ingelheim Investigational Site
city: Bruxelles
country: Belgium
facility: 1182.16.3207 Boehringer Ingelheim Investigational Site
city: Charleroi
country: Belgium
facility: 1182.16.3211 Boehringer Ingelheim Investigational Site
city: Gent
country: Belgium
facility: 1182.16.3204 Boehringer Ingelheim Investigational Site
city: Leuven
country: Belgium
facility: 1182.16.3201 Boehringer Ingelheim Investigational Site
city: Liège
country: Belgium
facility: 1182.16.3208 Boehringer Ingelheim Investigational Site
city: Liège
country: Belgium
facility: 1182.16.3212 Boehringer Ingelheim Investigational Site
city: Luxembourg
country: Belgium
facility: 1182.16.3209 Boehringer Ingelheim Investigational Site
city: Campinas - Sp
country: Brazil
facility: 1182.16.5511 Unidade de Pesquisa Clínica (UPC) - AIDS
city: Fortaleza - Ce
country: Brazil
facility: 1182.16.5505 Hospital São José de Doenças Infecciosas de Fortaleza
city: Porto Alegre - Rs
country: Brazil
facility: 1182.16.5502 Hospital Nossa Senhora da Conceiç
city: Porto Alegre - Rs
country: Brazil
facility: 1182.16.5504 Hospital das Clínicas de Porto Alegre
city: Porto Alegre - Rs
country: Brazil
facility: 1182.16.5512 Ambulatório de DST/ AIDS - RS
city: Rio de Janeiro - Rj
country: Brazil
facility: 1182.16.5509
city: Rio de Janeiro
country: Brazil
facility: 1182.16.5513 Centro de Pesquisa Hospital Evandro Chagras
city: Santos - Sp
country: Brazil
facility: 1182.16.5510
city: São Paulo - Sp
country: Brazil
facility: 1182.16.5501 UNIFESP/ Hospital São Paulo- Univers. Federal de São Paulo
city: São Paulo - Sp
country: Brazil
facility: 1182.16.5506 Casa da AIDS da FMUSP
city: São Paulo - Sp
country: Brazil
facility: 1182.16.5507 Hospital do Servidor Público Estadual de São Paulo
city: Vila Mariana
country: Brazil
facility: 1182.16.5508
city: Calgary
country: Canada
facility: 1182.16.1118
state: Alberta
city: Edmonton
country: Canada
facility: 1182.16.1104 University of Alberta H-Site
state: Alberta
city: Vancouver
country: Canada
facility: 1182.16.1101 St. Paul's Hospital
state: British Columbia
city: Vancouver
country: Canada
facility: 1182.16.1111 Downtown Infectious Diseases Clinic
state: British Columbia
city: Winnipeg
country: Canada
facility: 1182.16.1125 St. Boniface General Hospital
state: Manitoba
city: Moncton
country: Canada
facility: 1182.16.1131 The Moncton Hospital
state: New Brunswick
city: Halifax
country: Canada
facility: 1182.16.1128 Centre for Clinical Research
state: Nova Scotia
city: Hamilton
country: Canada
facility: 1182.16.1112 McMaster University Medical Centre
state: Ontario
city: London
country: Canada
facility: 1182.16.1126 HIV Care Programme
state: Ontario
city: Oakville
country: Canada
facility: 1182.16.1132 Infectious Diseases Consultant
state: Ontario
city: Toronto
country: Canada
facility: 1182.16.1102 Canadian Immunodeficiency Research Collaborative Inc.
state: Ontario
city: Toronto
country: Canada
facility: 1182.16.1107 Sunnybrook & Woman's College Health Science Centre
state: Ontario
city: Toronto
country: Canada
facility: 1182.16.1109 Infectious Diseases and HIV
state: Ontario
city: Toronto
country: Canada
facility: 1182.16.1110 Toronto East General Hospital
state: Ontario
city: Toronto
country: Canada
facility: 1182.16.1114 Toronto General Hospital
state: Ontario
city: Toronto
country: Canada
facility: 1182.16.1115
state: Ontario
city: Toronto
country: Canada
facility: 1182.16.1124
state: Ontario
city: Whitby
country: Canada
facility: 1182.16.1106 Positive Care Clinic
state: Ontario
city: Windsor
country: Canada
facility: 1182.16.1120 Metropolitan Campus
state: Ontario
city: Monteal
country: Canada
facility: 1182.16.1116 Immune Deficiency Treatment Centre
state: Quebec
city: Montreal
country: Canada
facility: 1182.16.1103 Hopital Notre Dame CHUM
state: Quebec
city: Montreal
country: Canada
facility: 1182.16.1113 Montreal Chest Institute, McGill University Health Centre
state: Quebec
city: Montreal
country: Canada
facility: 1182.16.1117 Clinique medicale l'Actuel
state: Quebec
city: Montreal
country: Canada
facility: 1182.16.1119
state: Quebec
city: Montreal
country: Canada
facility: 1182.16.1122 Infectious Diseases
state: Quebec
city: Montreal
country: Canada
facility: 1182.16.1130 Clinique Medicale LORI
state: Quebec
city: Copenhagen
country: Denmark
facility: 1182.16.4501 Boehringer Ingelheim Investigational Site
city: Hvidovre
country: Denmark
facility: 1182.16.4502 Boehringer Ingelheim Investigational Site
city: Odense C
country: Denmark
facility: 1182.16.4504 Boehringer Ingelheim Investigational Site
city: Vic (Barcelona)
country: El Salvador
facility: 1182.16.3491 Boehringer Ingelheim Investigational Site
city: Vizcaya
country: El Salvador
facility: 1182.16.3464 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 1182.16.3001 "Andreas Syggros"Hospital of Dermatological & Veneral Diseas
city: Athens
country: Greece
facility: 1182.16.3002 "Greek Red Cross" Hospital, 3rd Internal Medicine Clinic
city: Athens
country: Greece
facility: 1182.16.3004 "Attiko" Hospital, 4th Internal Medicine Clinic, UOA
city: Athens
country: Greece
facility: 1182.16.3005 Laiko Hospital, 2nd District Blood Donation Center & Haemato
city: Athens
country: Greece
facility: 1182.16.3007 1st Social Insurance Foundation (IKA) Pentelis
city: Patras
country: Greece
facility: 1182.16.3010 University Hospital of Patras
city: Piraeus
country: Greece
facility: 1182.16.3008 "Tzanio" Hospital
city: Thessaloniki
country: Greece
facility: 1182.16.3009 AHEPA Hospital
city: Ancona
country: Italy
facility: 1182.16.3932 Azienda Ospedaliera Umberto I
city: Antella (fi)
country: Italy
facility: 1182.16.3923 Ospedale Santa Maria Annunziata
city: Aviano - PD
country: Italy
facility: 1182.16.3952 Centro di riferimento oncologico
city: Bari
country: Italy
facility: 1182.16.3958 A.O. Ospedale Clinico Consorziale
city: Bergamo
country: Italy
facility: 1182.16.3920 Ospedali Riuniti di Bergamo
city: Bologna
country: Italy
facility: 1182.16.3946 Ospedale Policlinico S. Orsola Bologna
city: Bolzano
country: Italy
facility: 1182.16.3938 Ospedale Civile Regionale
city: Brescia
country: Italy
facility: 1182.16.3901 Università di Brescia
city: Brescia
country: Italy
facility: 1182.16.3957 A.O. Spedali Civili di Brescia
city: Busto Arsizio (va)
country: Italy
facility: 1182.16.3928 Azienda Ospedaliera
city: Cagliari
country: Italy
facility: 1182.16.3964 Ospedale SS. Trinità
city: Catania
country: Italy
facility: 1182.16.3947 U.O. Malattie Infettive
city: Catanzaro
country: Italy
facility: 1182.16.3961 Ospedale Pugliese
city: Cuggiono-MI
country: Italy
facility: 1182.16.3954 Ospedale Civile
city: Ferrara
country: Italy
facility: 1182.16.3963 Azienda Ospedaliera Arcispedale S. Anna
city: Firenze
country: Italy
facility: 1182.16.3924 Azienda Ospedaliera Careggi
city: Foggia
country: Italy
facility: 1182.16.3902 Ospedali Riuniti di Foggia
city: Foggia
country: Italy
facility: 1182.16.3911 U.O. di Malattie Infettive
city: Genova
country: Italy
facility: 1182.16.3926 Azienda Ospedaliera
city: Genova
country: Italy
facility: 1182.16.3927 Azienda Ospedaliera
city: Genova
country: Italy
facility: 1182.16.3929 Malattie Infettive
city: Lecco
country: Italy
facility: 1182.16.3912 Ospedale "A. Manzoni"
city: Mantova
country: Italy
facility: 1182.16.3925 Azienda Ospedaliera Carlo Poma
city: Mestre-VE
country: Italy
facility: 1182.16.3951 Ospedale Civile Umberto I
city: Milano
country: Italy
facility: 1182.16.3903 Ospedale L. Sacco
city: Milano
country: Italy
facility: 1182.16.3904 Ospedale Luigi Sacco
city: Milano
country: Italy
facility: 1182.16.3910 Ospedale Luigi Sacco
city: Milano
country: Italy
facility: 1182.16.3913 Fondazione Centro S. Raffaele del Monte Tabor
city: Milano
country: Italy
facility: 1182.16.3953 ospedale Niguarda
city: Milano
country: Italy
facility: 1182.16.3965 Ospedale Maggiore
city: Modena
country: Italy
facility: 1182.16.3968 Azienda Ospedaliera Policlinico
city: Napoli
country: Italy
facility: 1182.16.3934 Azienda Ospedaliera D. Cotugno
city: Napoli
country: Italy
facility: 1182.16.3937 Azienda Ospedaliera D. Cotugno
city: Padova
country: Italy
facility: 1182.16.3942 Azienda Ospedaliera di Padova
city: PALLANZA (Verbania)
country: Italy
facility: 1182.16.3914 Presidio Ospedaliero di Verbania
city: Parma
country: Italy
facility: 1182.16.3948 U.O. Malattie Infettive ed Epatologia
city: Pavia
country: Italy
facility: 1182.16.3909 I.R.C.C.S. Policlinico San Matteo
city: Pavia
country: Italy
facility: 1182.16.3921 IRCCS Policlinico San Matteo
city: Perugia
country: Italy
facility: 1182.16.3966 Policlinico Monteluce
city: Pesaro
country: Italy
facility: 1182.16.3955 Ospedale San Salvatore
city: Pescara
country: Italy
facility: 1182.16.3967 Ospedale Civile dello Spirito Santo
city: Pisa
country: Italy
facility: 1182.16.3944 Ospedale Cisanello
city: Ravenna
country: Italy
facility: 1182.16.3931 Ospedale Santa Maria delle Croci
city: Reggio Emilia
country: Italy
facility: 1182.16.3930 Arcispedale S. Maria Nuova
city: Roma
country: Italy
facility: 1182.16.3905 IRCCS Lazzaro Spallanzani
city: Roma
country: Italy
facility: 1182.16.3906 IRCCS Lazzaro Spallanzani
city: Roma
country: Italy
facility: 1182.16.3907 IRCCS Lazzaro Spallanzani
city: Roma
country: Italy
facility: 1182.16.3908 IRCCS Lazzaro Spallanzani
city: Roma
country: Italy
facility: 1182.16.3915 Azienda Policlinico Umberto I
city: Roma
country: Italy
facility: 1182.16.3922 Università "La Sapienza"
city: Roma
country: Italy
facility: 1182.16.3941 Istituto Nazionale per le Malattie Infettive
city: Roma
country: Italy
facility: 1182.16.3960 Università Cattolica del Sacro Cuore
city: Sassari
country: Italy
facility: 1182.16.3945 Istituto Malattie Infettive Università Di Sassari
city: Statte (ta)
country: Italy
facility: 1182.16.3970 Ospedale San Giuseppe Moscati
city: Torino
country: Italy
facility: 1182.16.3917 Ospedale Amedeo di Savoia
city: Torino
country: Italy
facility: 1182.16.3918 Ospedale Amedeo di Savoia
city: Torino
country: Italy
facility: 1182.16.3919 Ospedale Amedeo di Savoia
city: Torrette Di Ancona
country: Italy
facility: 1182.16.3933 Azienda Ospedaliera Umberto I
city: Torrette Di Ancona
country: Italy
facility: 1182.16.3939 Ospedale Regionale
city: Treviso
country: Italy
facility: 1182.16.3940 Presidio Ospedaliero Cà Foncello
city: Udine
country: Italy
facility: 1182.16.3943 Policlinico Universitario di Udine
city: Varese
country: Italy
facility: 1182.16.3916 Ospedale di Circolo e Fondazione Macchi
city: Venezia
country: Italy
facility: 1182.16.3950 Ospedale SS. Giovanni e Paolo
city: Verona
country: Italy
facility: 1182.16.3949 Policlinico Rossi "Borgo Roma"
city: Vicenza
country: Italy
facility: 1182.16.3959 Ospedale Civile di Vicenza - USSL 6
city: Lisboa
country: Portugal
facility: 1182.16.3503 Centro Hospitalar de Lisboa
city: Lisbon
country: Portugal
facility: 1182.16.3502 Hospital São Francisco Xavier
city: Lisbon
country: Portugal
facility: 1182.16.3505 Hospital Santa Maria
city: Matosinhos
country: Portugal
facility: 1182.16.3501 Unidade Local de Saúde de Matosinhos
city: Porto
country: Portugal
facility: 1182.16.3504 Hospital Joaquim Urbano
city: A Coruña
country: Spain
facility: 1182.16.3419 Boehringer Ingelheim Investigational Site
city: Alcalá de Henares (Madrid)
country: Spain
facility: 1182.16.3412 Boehringer Ingelheim Investigational Site
city: Alicante
country: Spain
facility: 1182.16.3432 Boehringer Ingelheim Investigational Site
city: Almeria
country: Spain
facility: 1182.16.3484 Boehringer Ingelheim Investigational Site
city: Arrecife (Lanzarote)
country: Spain
facility: 1182.16.3487 Boehringer Ingelheim Investigational Site
city: Aviles (Asturias)
country: Spain
facility: 1182.16.3474 Boehringer Ingelheim Investigational Site
city: Badalona
country: Spain
facility: 1182.16.3440
city: Baracaldo (Vizcaya)
country: Spain
facility: 1182.16.3454 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 1182.16.3438 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 1182.16.3442 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 1182.16.3448 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 1182.16.3449 Boehringer Ingelheim Investigational Site
city: Bilbao
country: Spain
facility: 1182.16.3463 Boehringer Ingelheim Investigational Site
city: Cadiz
country: Spain
facility: 1182.16.3476 Boehringer Ingelheim Investigational Site
city: Cartagena
country: Spain
facility: 1182.16.3430 Boehringer Ingelheim Investigational Site
city: Castellón
country: Spain
facility: 1182.16.3462 Boehringer Ingelheim Investigational Site
city: Cordoba
country: Spain
facility: 1182.16.3429 Boehringer Ingelheim Investigational Site
city: El Palmar (MURCIA)
country: Spain
facility: 1182.16.3431 Boehringer Ingelheim Investigational Site
city: Gandia (Valencia)
country: Spain
facility: 1182.16.3488 Boehringer Ingelheim Investigational Site
city: Gerona
country: Spain
facility: 1182.16.3443 Boehringer Ingelheim Investigational Site
city: Getafe (Madrid)
country: Spain
facility: 1182.16.3411 Boehringer Ingelheim Investigational Site
city: Gijón (ASTURIAS)
country: Spain
facility: 1182.16.3418 Boehringer Ingelheim Investigational Site
city: Granada
country: Spain
facility: 1182.16.3427 Boehringer Ingelheim Investigational Site
city: Granada
country: Spain
facility: 1182.16.3428 Boehringer Ingelheim Investigational Site
city: Granollers (Barcelona)
country: Spain
facility: 1182.16.3439 Boehringer Ingelheim Investigational Site
city: Hospitalet de Llobregat (Barcelona)
country: Spain
facility: 1182.16.3477 Boehringer Ingelheim Investigational Site
city: Hospitalet de Llobregat
country: Spain
facility: 1182.16.3445 Boehringer Ingelheim Investigational Site
city: Huelva
country: Spain
facility: 1182.16.3480 Boehringer Ingelheim Investigational Site
city: Ibiza
country: Spain
facility: 1182.16.3498 Boehringer Ingelheim Investigational Site
city: Jaen
country: Spain
facility: 1182.16.3479 Boehringer Ingelheim Investigational Site
city: Jerez de la Frontera
country: Spain
facility: 1182.16.3423 Boehringer Ingelheim Investigational Site
city: La Laguna (santa Cruz de Tenerife)
country: Spain
facility: 1182.16.3436 Boehringer Ingelheim Investigational Site
city: Las Palmas de Gran Canarias
country: Spain
facility: 1182.16.3437 Boehringer Ingelheim Investigational Site
city: Las Palmas de Gran Canaria
country: Spain
facility: 1182.16.3434 Boehringer Ingelheim Investigational Site
city: Leganés (Madrid)
country: Spain
facility: 1182.16.3470 Boehringer Ingelheim Investigational Site
city: Lleida
country: Spain
facility: 1182.16.3441 Boehringer Ingelheim Investigational Site
city: Logroño
country: Spain
facility: 1182.16.3490 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3401 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3402 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3404 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3405 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3406 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3407 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3408 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3409 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1182.16.3413 Boehringer Ingelheim Investigational Site
city: Malaga
country: Spain
facility: 1182.16.3424 Boehringer Ingelheim Investigational Site
city: Manresa (Barcelona)
country: Spain
facility: 1182.16.3494 Boehringer Ingelheim Investigational Site
city: Marbella (Málaga)
country: Spain
facility: 1182.16.3426 Boehringer Ingelheim Investigational Site
city: Mataro
country: Spain
facility: 1182.16.3493 Boehringer Ingelheim Investigational Site
city: Mataró (Barcelona)
country: Spain
facility: 1182.16.3492
city: Málaga
country: Spain
facility: 1182.16.3425 Boehringer Ingelheim Investigational Site
city: Móstoles (Madrid)
country: Spain
facility: 1182.16.3410 Boehringer Ingelheim Investigational Site
city: Navarra
country: Spain
facility: 1182.16.3489 Boehringer Ingelheim Investigational Site
city: Ourense
country: Spain
facility: 1182.16.3472 Boehringer Ingelheim Investigational Site
city: Oviedo (Asturias)
country: Spain
facility: 1182.16.3417 Boehringer Ingelheim Investigational Site
city: Palma de Mallorca
country: Spain
facility: 1182.16.3496 Boehringer Ingelheim Investigational Site
city: Plama de Mallorca
country: Spain
facility: 1182.16.3450 Boehringer Ingelheim Investigational Site
city: Reus (Tarragona)
country: Spain
facility: 1182.16.3497 Boehringer Ingelheim Investigational Site
city: Sabadell (Barcelona)
country: Spain
facility: 1182.16.3446 Boehringer Ingelheim Investigational Site
city: San Sebastian
country: Spain
facility: 1182.16.3453 Boehringer Ingelheim Investigational Site
city: Santa Cruz de Tenerife
country: Spain
facility: 1182.16.3435 Boehringer Ingelheim Investigational Site
city: Santander
country: Spain
facility: 1182.16.3455 Boehringer Ingelheim Investigational Site
city: Santiago de Compostela
country: Spain
facility: 1182.16.3415 Boehringer Ingelheim Investigational Site
city: Sevilla
country: Spain
facility: 1182.16.3420 Boehringer Ingelheim Investigational Site
city: Sevilla
country: Spain
facility: 1182.16.3421 Boehringer Ingelheim Investigational Site
city: Sevilla
country: Spain
facility: 1182.16.3422 Boehringer Ingelheim Investigational Site
city: Tarragona
country: Spain
facility: 1182.16.3447 Boehringer Ingelheim Investigational Site
city: Tarragona
country: Spain
facility: 1182.16.3495 Boehringer Ingelheim Investigational Site
city: Terrassa
country: Spain
facility: 1182.16.3444 Boehringer Ingelheim Investigational Site
city: Valencia
country: Spain
facility: 1182.16.3456 Boehringer Ingelheim Investigational Site
city: Valencia
country: Spain
facility: 1182.16.3457 Boehringer Ingelheim Investigational Site
city: Valencia
country: Spain
facility: 1182.16.3458 Boehringer Ingelheim Investigational Site
city: Valencia
country: Spain
facility: 1182.16.3460 Boehringer Ingelheim Investigational Site
city: Valencia
country: Spain
facility: 1182.16.3461 Boehringer Ingelheim Investigational Site
city: Valladolid
country: Spain
facility: 1182.16.3403 Boehringer Ingelheim Investigational Site
city: Vigo (Pontevedra)
country: Spain
facility: 1182.16.3467 Boehringer Ingelheim Investigational Site
city: Vigo
country: Spain
facility: 1182.16.3416 Boehringer Ingelheim Investigational Site
city: Villajoyosa (ALICANTE)
country: Spain
facility: 1182.16.3482 Boehringer Ingelheim Investigational Site
city: Vitoria
country: Spain
facility: 1182.16.3483 Boehringer Ingelheim Investigational Site
city: Zamora
country: Spain
facility: 1182.16.3471 Boehringer Ingelheim Investigational Site
city: Zaragoza
country: Spain
facility: 1182.16.3451 Boehringer Ingelheim Investigational Site
city: zARAGOZA
country: Spain
facility: 1182.16.3452 Boehringer Ingelheim Investigational Site
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References: